Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibrutinib in CLL and SLL
NCT01105247Phase 2Completed
- Sponsor
- Pharmacyclics
- Start
- May 2010
- Primary completion
- Dec 2012
- Countries
- 1
01
Overview
A Phase 2 trial of ibrutinib in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by Pharmacyclics. Started May 2010; status: completed.
02
Drugs
ibrutinib
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT01105247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01105247.